AI Giant Anthropic Warns of Existential Risks in $2 Trillion IPO Bid, While AstraZeneca Invests $2 Billion in Cancer Drug Development
AI firm Anthropic has disclosed 'catastrophic or existential risks to humanity' from advanced AI in its IPO filing, seeking a $2 trillion valuation. Meanwhile, AstraZeneca inks a $2 billion deal to co-develop a promising cancer drug.